Welcome to our dedicated page for INNOVATIVE EYEWEAR SEC filings (Ticker: LUCYW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Smart eyewear sounds simple until you open Innovative Eyewear’s latest 10-K and face pages of patent jargon, equity raises and segment data on Lucyd® and Nautica® frames. If you have ever asked, “How do I read Innovative Eyewear’s annual report 10-K simplified?” or “Where are those Innovative Eyewear insider trading Form 4 transactions?” you know the challenge.
Stock Titan solves it. Our platform delivers AI-powered summaries that turn dense disclosures into plain-English insight—highlighting R&D spend behind ChatGPT-enabled glasses, cash burn from manufacturing scale-up, and licensing revenue terms. Need the next Innovative Eyewear quarterly earnings report 10-Q filing? It arrives here the moment it hits EDGAR, complete with key metrics and trend visuals. Curious about a sudden executive sale? Get Innovative Eyewear Form 4 insider transactions real-time, including context on option grants and vesting.
Use this page to:
- Track every 8-K material event—new retail partnerships or patent wins—Innovative Eyewear 8-K material events explained.
- Compare quarter-over-quarter revenue through our Innovative Eyewear earnings report filing analysis.
- Review the proxy statement for detailed Innovative Eyewear executive compensation data.
- Monitor Innovative Eyewear executive stock transactions Form 4 before product launches.
Whether you’re an analyst measuring dilution risk, or a retail investor trying to understand Bluetooth component costs, our real-time feed and expert commentary keep every Innovative Eyewear SEC filing explained simply. Stop scrolling through PDFs—start understanding Innovative Eyewear SEC documents with AI in seconds.
Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) discloses a proposed sale of 760 common shares through Raymond James on 09/10/2025 on the NASDAQ with an aggregate market value of $1,611.20. The securities were acquired as an RSU grant on 08/19/2025 totaling 7,200 shares with payment in cash recorded on the same date. The filing also lists a prior sale by the reporting person of 2,225 shares on 08/19/2025 generating $4,422.00 in gross proceeds. The notice includes the standard representation that the seller does not possess undisclosed material information.
Innovative Eyewear, Inc. (ticker: LUCYW) Form 144 notice reports a proposed sale of 2,596 common shares valued at an aggregate $5,057.55 to be sold through Raymond James & Associates on 08/19/2025 on NASDAQ. The filer shows the shares were acquired the same day, 08/19/2025, as an RSU grant from the issuer representing 8,400 shares granted, with the reported form indicating cash payment. The filing lists total shares outstanding as 4,574,602. No securities were reported sold by the filer in the prior three months and no additional remarks or plan-adoption dates are provided.
Form 144 notice: A person affiliated with Innovative Eyewear, Inc. (ticker LUCYW) notified a proposed sale of 1,485 common shares08/19/2025. The filing lists an aggregate market value of $2,889.95 for the shares and reports 4,574,602 shares outstanding. The securities were acquired the same day as an RSU grant dated 08/19/2025 for 4,800 shares, with cash listed as the payment method. The filer attests they are not aware of any undisclosed material adverse information about the issuer.
Innovative Eyewear, Inc. (LUCYW) Form 144 reports a proposed sale of 3,009 common shares to be executed through Raymond James & Associates on 08/19/2025 on NASDAQ. The filing lists an aggregate market value of $5,894.17 for the shares and states total shares outstanding of 4,574,602, providing the basic size and timing of the planned transaction.
The securities were acquired as an RSU grant on 08/19/2025 (noted amount: 9,600 shares) with cash listed as the payment type. The filer attests by signature that they do not possess undisclosed material adverse information about the issuer.
Form 144 notice for Innovative Eyewear, Inc. (symbol LUCYW) reports a proposed sale of 2,225 common shares through Raymond James on 08/19/2025 with an aggregate market value of $4,421.80. The filing shows the securities were acquired the same day as an RSU grant (8,200 units granted; 7,200 units listed as acquired) and payment is listed as cash. The issuer's outstanding shares are stated as 4,574,602. Several standard filer and issuer contact fields are blank in the submission.
Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) shows a proposed sale of 1,670 common shares through Raymond James on 08/19/2025 on NASDAQ with an aggregate market value of $3,317.35. The filing reports the securities were acquired as an RSU grant from the issuer on 08/19/2025, with 5,400 units acquired and payment marked as cash. The issuer’s total shares outstanding are listed as 4,574,602. The filer certifies they are not aware of undisclosed material adverse information and indicates no securities sold in the prior three months.
Innovative Eyewear's Schedule 13G/A reports that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC collectively beneficially own 475,728 shares of common stock, representing approximately 9.99% of the outstanding shares as of June 30, 2025. That total consists of 288,282 shares held by Intracoastal and 187,446 shares issuable upon exercise of Intracoastal Warrant 1. The filing discloses multiple additional warrant tranches excluded from the reported percentage because of blocker provisions, and states that without those blockers the group could be deemed to beneficially own 2,616,499 shares. The reporting persons indicate 0 sole voting power and shared voting and dispositive power over the reported 475,728 shares and certify the holdings were not acquired to change or influence control.
FAQ
What is the current stock price of INNOVATIVE EYEWEAR (LUCYW)?
